PSA is the antigen that is currently used to help detect whether or not a patient is at risk for or already has prostate cancer. Prostate cancer in the early stages usually shows no signs or symptoms. It is imperative that males who are in the risk categories for developing prostate cancer have an annual screening done by their physicians. These screenings can include the PSA blood test.
The PSA level for a normal, healthy patient is usually below four. High levels indicate that the patient is at risk or already has prostate cancer. In younger patients, these guidelines are lowered because smaller prostates produce lower PSA levels. At 2.5, these patients are now considered to be at risk for developing prostate cancer.
Every year, nearly 200,000 Americans are diagnosed with this disease, and 30,000 end up dying from it. It is extremely important that this cancer is caught in the early stages. Annual screening exams such as the digital rectal exam and the PSA blood test have led to more men being diagnosed in the early stages of this cancer.
The tumor-node-metastasis (TNM) system is the most common system used to determine the stages of prostate cancer.
· T1 prostate tumors have microscopic tumors that cannot be felt during the digital rectal examination.
· T2 prostate tumors will be felt during the digital rectal examination and are confined to the prostate gland itself.
· T3 prostate tumors have usually grown to not only include the prostate gland but also surrounding structures, such as the capsule of connective tissue that surrounds the prostate gland.
· T4 prostate tumors have grown to involve not only the surrounding structures but also nearby tissues.
Early stage of this cancer that is still confined to a local area can be treated through different options. Most commonly, in the early stages, treatment involves a surgical procedure that removes the tumor and/or the entire prostate gland. Other options for treatment include radiation therapy and active surveillance.
By having the entire prostate removed, the chances for a patient to be cancer-free for up to fifteen years
When it comes to prostate, the familiar adage that an ounce of prevention is worth a pound of cure is particularly apt. Although there is no way to guarantee that one prostate protocol reviews 2021 will never be diagnosed with the disease, there are a handful of easy changes that a person can make in their lifestyle that will significantly lower their risk. Maintaining a healthy weight has been shown to lower the chance of developing prostate cancer, as has adopting a diet that is low in fat. However, the most effective method of preventing prostate cancer has been proven to be getting the proper nutrients that the prostate needs through diet and nutritional supplements.
after surgery is 80% to 85%. After the prostate gland is removed, the bladder and the urethra are reconnected.
Radiation therapy can be done in one of two ways: either through the use of external beam radiation or internal radiation. EBRT (external beam radiation therapy) is usually given five days per week for approximately 5 to 8 weeks, depending upon whether this therapy is used alone or in combination with other treatments.
Brachytherapy (internal radiation) can be performed for this form of cancer. (Brachytherapy is also used to help treat other forms of cancer.) This usually involves placing a tube into the prostate gland and administering direct radiation through ultrasound guidance.
Early stages of this cancer are easily treated and can yield high prognosis survival rates. You can help to detect early stage prostate cancer just by scheduling an annual screening with your physician. This is a small price to pay to stay cancer free.